{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:01:48Z","timestamp":1793131308147,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002661","name":"FRS-FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","cysticfibrosisjournal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jcf.2024.02.012","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T06:28:37Z","timestamp":1708756117000},"page":"1146-1152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Repurposing DNase I and alginate lyase to degrade the biofilm matrix of dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa grown in artificial sputum medium: In-vitro assessment of their activity in combination with broad-spectrum antibiotics"],"prefix":"10.1016","volume":"23","author":[{"given":"Zhifen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-8771","authenticated-orcid":false,"given":"Rita","family":"Vanbever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Lorent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Solis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Van Bambeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.02.012_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1465-9921-4-8","article-title":"State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?","volume":"4","author":"Chmiel","year":"2003","journal-title":"Respir Res"},{"key":"10.1016\/j.jcf.2024.02.012_bib0002","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcf.2024.02.012_bib0003","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jcf.2024.02.012_bib0004","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41579-022-00682-4","article-title":"Tolerance and resistance of microbial biofilms","volume":"20","author":"Ciofu","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jcf.2024.02.012_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/AAC.39.1.34","article-title":"Macromolecular mechanisms of sputum inhibition of tobramycin activity","volume":"39","author":"Hunt","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcf.2024.02.012_bib0006","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/AAC.01650-15","article-title":"Extracellular DNA acidifies biofilms and induces aminoglycoside resistance in Pseudomonas aeruginosa","volume":"60","author":"Wilton","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcf.2024.02.012_bib0007","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/rccm.202004-1322OC","article-title":"Sustained coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in cystic fibrosis","volume":"203","author":"Fischer","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.02.012_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00559-19","article-title":"Exogenous alginate protects Staphylococcus aureus from killing by Pseudomonas aeruginosa","volume":"202","author":"Price","year":"2020","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jcf.2024.02.012_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41522-017-0035-0","article-title":"Staphylococcus aureus interaction with Pseudomonas aeruginosa biofilm enhances tobramycin resistance","volume":"3","author":"Beaudoin","year":"2017","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.jcf.2024.02.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2020.100027","article-title":"Biofilm dispersion: the key to biofilm eradication or opening Pandora's box?","volume":"2","author":"Wille","year":"2020","journal-title":"Biofilm"},{"key":"10.1016\/j.jcf.2024.02.012_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00291-22","article-title":"Effects of mucin and DNA concentrations in airway mucus on Pseudomonas aeruginosa biofilm recalcitrance","volume":"7","author":"Rouillard","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.jcf.2024.02.012_bib0012","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/pulp.1994.1042","article-title":"Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity","volume":"7","author":"Mrsny","year":"1994","journal-title":"Pulm Pharmacol"},{"key":"10.1016\/j.jcf.2024.02.012_bib0013","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11095-009-9991-2","article-title":"Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis","volume":"27","author":"Yang","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jcf.2024.02.012_bib0014","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/pulp.1994.1042","article-title":"Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity","volume":"7","author":"Mrsny","year":"1994","journal-title":"Pulm Pharmacol"},{"key":"10.1016\/j.jcf.2024.02.012_bib0015","first-page":"653","article-title":"Clinical trials of recombinant human DNase in cystic fibrosis patients","volume":"48","author":"Aitken","year":"1993","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.jcf.2024.02.012_bib0016","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cells11111769","article-title":"CFTR modulators in people with cystic fibrosis: real-world evidence in France","volume":"11","author":"Regard","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jcf.2024.02.012_bib0017","doi-asserted-by":"crossref","first-page":"e02204","DOI":"10.1128\/AAC.02204-19","article-title":"Activity of antibiotics against Pseudomonas aeruginosa in an in Vitro model of biofilms in the context of cystic fibrosis: influence of the culture medium","volume":"64","author":"Diaz Iglesias","year":"2020","journal-title":"Antimicrob Ag Chemother"},{"key":"10.1016\/j.jcf.2024.02.012_bib0018","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.3389\/fmicb.2018.03291","article-title":"Maintenance of S. aureus in Co-culture with P. aeruginosa While Growing as Biofilms","volume":"9","author":"Woods","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2024.02.012_bib0019","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mimet.2014.07.010","article-title":"Evaluation of fluorescent stains for visualizing extracellular DNA in biofilms","volume":"105","author":"Okshevsky","year":"2014","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.jcf.2024.02.012_bib0020","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1017\/S1431927614000361","article-title":"Visualization of microbiological processes underlying stress relaxation in Pseudomonas aeruginosa biofilms","volume":"20","author":"Peterson","year":"2014","journal-title":"Microsc Microanal"},{"key":"10.1016\/j.jcf.2024.02.012_bib0021","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1042\/CS20180315","article-title":"Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum","volume":"132","author":"Guichard","year":"2018","journal-title":"Clin Sci"},{"key":"10.1016\/j.jcf.2024.02.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2019.100017","article-title":"Biofilm mechanics: implications in infection and survival","volume":"2","author":"Gloag","year":"2020","journal-title":"Biofilm"},{"key":"10.1016\/j.jcf.2024.02.012_bib0023","article-title":"Role of pyocyanin and extracellular DNA in facilitating Pseudomonas aeruginosa Biofilm formation","author":"Das","year":"2016","journal-title":"Microbial Biofilms"},{"key":"10.1016\/j.jcf.2024.02.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2023.100104","article-title":"Altering the viscoelastic properties of mucus-grown Pseudomonas aeruginosa biofilms affects antibiotic susceptibility","volume":"5","author":"Rouillard","year":"2023","journal-title":"Biofilm"},{"key":"10.1016\/j.jcf.2024.02.012_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1465-9921-10-63","article-title":"Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum","volume":"10","author":"Serisier","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.jcf.2024.02.012_bib0026","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/jac\/dkx293","article-title":"Patient-specific modelling of regional tobramycin concentration levels in airways of patients with cystic fibrosis: can we dose once daily?","volume":"72","author":"Bos","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcf.2024.02.012_bib0027","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/j.1875-9114.1997.tb03742.x","article-title":"Meropenem, a new carbapenem antibiotic","volume":"17","author":"Fish","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcf.2024.02.012_bib0028","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0463.2006.apm_356.x","article-title":"Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms","volume":"114","author":"Alkawash","year":"2006","journal-title":"APMIS"},{"key":"10.1016\/j.jcf.2024.02.012_bib0029","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ja.2011.113","article-title":"Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci","volume":"65","author":"Kaplan","year":"2012","journal-title":"J Antibiot"},{"key":"10.1016\/j.jcf.2024.02.012_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1517\/17425247.2.4.763","article-title":"Controlled inhalation of aerosolised therapeutics","volume":"2","author":"Bennett","year":"2005","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T04:38:18Z","timestamp":1733459898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1569199324000274"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.02.012","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing DNase I and alginate lyase to degrade the biofilm matrix of dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa grown in artificial sputum medium: In-vitro assessment of their activity in combination with broad-spectrum antibiotics","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}